TrialCPT: pharmacometrics & systems pharmacology2024

Population pharmacokinetic-pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine-refractory differentiated thyroid cancer (RR-DTC).

Oneeb Majid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.